TCRX Shares Outstanding History



Below is a table of the TCRX shares outstanding history going back to 7/16/2021:

Date TCRX Shares Outstanding
7/16/202118.36M
8/16/202118.82M
11/5/202118.62M
3/4/202223.98M
5/6/202218.89M
8/3/20225.14M
11/4/202218.94M
2/28/202319.08M
5/5/20234.75M
8/4/20234.28M
10/3/20234.28M
3/1/20244.28M

Also see: TCRX Market Cap History
TCRX YTD Return
TCRX Historical Shares Outstanding:
-42.57% CAGR
TCRX Historical Shares Outstanding: +-42.57% CAGR

Mouse over chart for data details
7/16/2021 ...3/1/2024
TScan Therapeutics is a clinical-stage biopharmaceutical company focused on developing a pipeline of T cell receptor-engineered T cell (TCR-T), therapies for the treatment of patients with cancer. Co.'s proprietary platform is designed to: discover anti-cancer TCRs from patients with exceptional responses to immunotherapy; discover TCRs that recognize clinically validated targets; identify off-targets of TCRs to eliminate candidates; and manufacture TCR-T therapies using Co.'s T-Integrate technology. The central elements of Co.'s platform that differentiate it from other cell therapy companies are TargetScan, ReceptorScan, SafetyScan, ImmunoBank and T-Integrate. We show 12 historical shares outstanding datapoints in our coverage of TCRX's shares outstanding history.

Understanding the changing numbers of TCRX shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like TCRX versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching TCRX by allowing them to research TCRX shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes

Email EnvelopeFree TCRX Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
TScan Therapeutics (TCRX) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

TDOC Shares Outstanding History
TECH Shares Outstanding History
TELA Shares Outstanding History
TENX Shares Outstanding History
TERN Shares Outstanding History
TEVA Shares Outstanding History
TFFP Shares Outstanding History
TFX Shares Outstanding History
TGTX Shares Outstanding History
THAR Shares Outstanding History
More Healthcare companies »

 

TCRX Shares Outstanding History | www.SharesOutstandingHistory.com | Copyright © 2017 - 2024, All Rights Reserved

Nothing in SharesOutstandingHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 9.5%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 9.5%.